Australian Drug Discovery Library (ADDL)
At the core of a successful drug discovery is a high-quality chemical library. A fit-for-purpose drug discovery library is not a random collection of compounds, but a collection of carefully curated chemistry that is designed to cover the diversity of drug-like chemistry space and provide tractable starting points for medicinal chemistry optimisation.
This project will build on a national framework to provide Australian drug discovery organisations access to a comprehensive Hit ID platform that includes:
- a fit for purpose drug discovery library (up to 300,000 compounds)
- an ultra-high throughput screening facility
- fragment-based drug design capability
- a state of the art software platform for in silico drug discovery.
State | Victoria |
Consortium lead | Canthera Discovery (CTx CRC Ltd) |
Consortium members | UniQuest, Walter and Eliza Hall Institute (WEHI), Children's Cancer Institute (CCI), Griffith University |
MTPConnect grant | $1,100,000 |
Industry contribution | $2,044,302 |
Project duration | August 2017 - June 2019 (Finished) |
Contact | info@alidc.com.au |
Website: Australian Lead Identification Consortium for more details